How long should I take Imatinib?

The length of treatment with Imatinib (Imatinib) usually depends on the patient’s specific disease type and condition. For patients with chronic myelogenous leukemia (CML), imatinib usually requires long-term use, possibly even lifelong use. This is because CML is a chronic disease that requires continued suppression of abnormal leukemia cells. For some other leukemias and neoplastic diseases, treatment duration may vary. Doctors will develop an individualized treatment plan based on the patient's condition, treatment response and molecular monitoring results. Some patients may be able to consider discontinuing the medication after a period of time, but this requires physician advice and close monitoring. In summary, the duration of imatinib treatment varies among individuals and depends on the type of disease and the patient's specific circumstances. Patients should work closely with their doctor, follow medical advice, and receive regular monitoring to ensure the disease is effectively controlled. Do not stop medication or change the medication regimen without medical guidance.